PER percheron therapeutics limited

It should be an interesting webinar on Thursday - plenty of...

  1. 3,170 Posts.
    lightbulb Created with Sketch. 556
    It should be an interesting webinar on Thursday  - plenty of things to question and discuss, I will be tuning in having registered already and look forward to more information on why the trial failed and where to from here!
    Hopefully, some clarity on the whole situation for the market to digest moving forward!

    "The Company is pleased to invite shareholders and investors to an investor update webinar and Q&A with CEO and Managing Director, Dr James Garner and Chief Medical Officer, Dr Cathryn Clary. The webinar will discuss the results of the phase IIb avicursen study in more detail, and will share emerging insights from the Company’s review.
    The webinar will be held Thursday 6 February 2025 at 9:00am (AEDT). Anyone wishing to attend the webinar is invited to register at the following link: https://us02web.zoom.us/webinar/register/WN_Ex9lCP6AQ_63SGulZlCogA
    After registering you will receive a confirmation email containing information about joining the webinar. A recording of the webinar will be available on the Company’s website shortly after the live session."

    Cheers, and best of luck to those still holding!
    .
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.0¢
Change
0.000(0.00%)
Mkt cap ! $10.87M
Open High Low Value Volume
1.0¢ 1.0¢ 1.0¢ $727 72.68K

Buyers (Bids)

No. Vol. Price($)
4 2840316 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 3323423 6
View Market Depth
Last trade - 12.00pm 20/06/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.